Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Genelux Corp. (GNLX) vs. Competitors

305 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GNLXGenelux Corp.$1.87$84.38M-2.10-66.15%Moderate BuyUnlock the GNLX analyst price target with TipRanks PremiumGNLXUnlock the GNLX top-analyst price target with TipRanks Premium
CHRSCoherus Biosciences$0.53$81.21M-0.54-58.33%Strong BuyUnlock the CHRS analyst price target with TipRanks PremiumGNLX vs CHRSUnlock the CHRS top-analyst price target with TipRanks Premium
FATEFate Therapeutics$1.28$155.61M-1.2429.03%Moderate BuyUnlock the FATE analyst price target with TipRanks PremiumGNLX vs FATEUnlock the FATE top-analyst price target with TipRanks Premium
TNXPTonix Pharma$3.01$58.49M-0.24-81.36%Strong BuyUnlock the TNXP analyst price target with TipRanks PremiumGNLX vs TNXPUnlock the TNXP top-analyst price target with TipRanks Premium
CRBPCorbus Pharmaceuticals$3.39$69.86M-0.53-69.38%Strong BuyUnlock the CRBP analyst price target with TipRanks PremiumGNLX vs CRBPUnlock the CRBP top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GNLXGenelux Corp.1.86-3.38-64.48%
CHRSCoherus Biosciences0.53-0.60-53.54%
FATEFate Therapeutics1.280.3131.55%
TNXPTonix Pharma3.01-13.79-82.09%
CRBPCorbus Pharmaceuticals3.39-7.86-69.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts